By binding SLC9A3R1 to activate autophagy and destabilize REST, OPRK1 reprograms prostate adenocarcinoma cells toward a NE lineage, thereby fueling ARPI resistance. The gene discussed is REST; the disease is prostate adenocarcinoma.